DeJarnette to buy Swearingen

Article

DeJarnette Research Systems has signed a letter of intent to acquire radiology information system (RIS) firm Swearingen Software of Houston. The purchase builds on the two firms’ partnership, announced last December at the RSNA (SCAN Special

DeJarnette Research Systems has signed a letter of intent to acquire radiology information system (RIS) firm Swearingen Software of Houston. The purchase builds on the two firms’ partnership, announced last December at the RSNA (SCAN Special Report 1/99). Towson, MD-based DeJarnette hopes Swearingen will strengthen DeJarnette’s position in the PACS and RIS markets. No financial terms of the transaction were released.

DeJarnette will integrate Swearingen Software’s RMS RIS into Radiance, its PACS product line. DeJarnette hopes to begin shipping Radiance by the end of the year. Swearingen will remain at its Houston headquarters, although its sales, marketing, and business operations will be combined with DeJarnette’s Towson offices. Company president Randall Swearingen will become vice president of information systems and operations for DeJarnette. DeJarnette does not expect any layoffs or cancellations of existing products as a result of the purchase.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.